Latica Insights.

The latest industry news, interviews, technologies, and resources.

10.14.26

GLP-1 Prescribing Is Quietly Becoming a Retention Strategy for GI Practices

Most conversations about GLP-1s focus on weight loss, supply, or cost. In our GI practice data we see something else is happening that deserves just as much attention: patients who start a GLP-1 or other GLP-1 Receptor Agonists, (GLP-1 RAs) come back to see their doctor far more often. Using our extensive EHR and claims […]
07.13.26

AI-Driven Quality Improvement for Colonoscopy Surveillance: 97.5% Recall Resolution in Adenoma Patients Across 1.2 Million Procedures

DDW 2026 Research Summary · Latica & Gastro Health Presented at DDW 2026 (Digestive Disease Week) · Community Gastroenterology Practice Group, Multi-State (Gastro Health) · AI Partner: Latica 1.2M Colonoscopy procedures analyzed 97.5% Recall resolution in adenoma patients (retrospective, up from 87%) 93.2% Of all procedures achieved a resolved recall plan 100% Scheduling completion for […]
03.17.25

Exploring the Intersection of Inflammation & Immunology Diseases

Inflammation and Immunology (I&I) is at the heart of many chronic and debilitating diseases, spanning multiple healthcare verticals. These diseases are characterized by overactive or misdirected immune responses, leading to tissue damage, impaired function, and significant patient burden.

  • 10.14.26 | Post

    GLP-1 Prescribing Is Quietly Becoming a Retention Strategy for GI Practices

    Read More

  • 06.15.25 | Research

    Latica Partners Showcase Groundbreaking Research at ARS 2024 Symposium

    Read More

  • 10.06.24 | Research

    Latica Partners Showcase Groundbreaking Research at ARS 2024 Symposium

    Read More

  • 07.03.24 | Research

    Revolutionize IBD Treatment Through Real-World Data

    Read More

  • 07.03.24 | Research

    Crohn’s Colitis Congress 2024 Poster Presentation

    Read More

  • 07.13.26 | Post

    AI-Driven Quality Improvement for Colonoscopy Surveillance: 97.5% Recall Resolution in Adenoma Patients Across 1.2 Million Procedures

    Read More

  • 07.22.25 | Post

    Unlocking Dermatology Insights: Going Beyond Codes with Real-World Clinical Data

    Read More

  • 03.17.25 | Post

    Exploring the Intersection of Inflammation & Immunology Diseases

    Read More

  • 01.07.25 | Post

    Reflecting on 2024 and Looking Ahead to 2025

    Read More

  • 12.19.24 | Post

    Lynx.MD is now Latica: A New Healthcare Ecosystem for Advanced Collaboration

    Read More
‹
  • 1
  • 2
  • 3
  • 4
›